Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is April 23, 2024.
All times in Eastern Daylight Time.
-
Nidec Announces Financial Results for Fiscal Year Ended March 31, 2024KYOTO, Japan--(BUSINESS WIRE)--Nidec Corporation (TOKYO: 6594) (OTC US: NJDCY) today announced its consolidated financial results under the International Financial Reporting Standards (“IFRS”) for ... more »
-
BIRMINGHAM, Ala.--(BUSINESS WIRE)--Hibbett, Inc. (“Hibbett”) (Nasdaq:HIBB), an athletic-inspired fashion retailer, today announced a definitive agreement in which JD Sports Fashion plc (“JD Sports”... more »
-
LONDON--(BUSINESS WIRE)-- City of Stockholm Issue of SEK 2,550,000,000.00 Floating rate notes due April 2028 Series EMTN93 Tranche 1 MTN ISSUE NAME. Our Ref. MP5722 ISIN Code. XS2615308132 TOTAL I... more »
-
Lancement en Europe par Antech de l'outil révolutionnaire de dépistage du cancer, dédié à la détection précoce du cancer caninViernheim, Allemagne--(BUSINESS WIRE)--Antech, la société de diagnostic vétérinaire qui s'associe aux professionnels vétérinaires pour anticiper, diagnostiquer et surveiller le bien-être et la mala... more »
-
TME PHARMA ANNONCE QUE 33% DES PATIENTS AYANT REÇU LE NOX-A12 EN COMBINAISON AVEC LE BEVACIZUMAB ET LA RADIOTHÉRAPIE ONT ATTEINT DEUX ANS DE SURVIE DANS L'ESSAI DE PHASE 1/2 GLORIA DANS LE CANCER DU CERVEAUBERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris : ALTME), société de biotechnologie spécialisée dans le développement de nouvelles thérapies pour le traitement du c... more »
-
Markteinführung des bahnbrechenden Screening-Tests von Antech in Europa zur Früherkennung von Krebs bei HundenViernheim, Deutschland--(BUSINESS WIRE)--Antech, ein Unternehmen der Veterinärdiagnostik und Partner an der Seite von Tierärztinnen und Tierärzten bei der Prognose, Diagnose und Überwachung von Ges... more »
-
Lancio in Europa del rivoluzionario strumento di screening tumorale di Antech, a supporto della diagnosi precoce delle neoplasie del caneViernheim, Germania--(BUSINESS WIRE)--Antech, azienda di diagnostica veterinaria specializzata nella collaborazione con medici veterinari per la prognosi, la diagnosi e il monitoraggio del benesser... more »
-
LIMOGES, France--(BUSINESS WIRE)--Regulatory News: Legrand (Paris:LR) poursuit activement sa stratégie de développement avec l’annonce de deux acquisitions dans les domaines porteurs de l’assistanc... more »
-
LONDON--(BUSINESS WIRE)-- The Trafford Centre Finance Limited GBP 69,550,000 Class D1 (N) Floating Rate Secured Notes due 2035 ISSUE NAME. Our Ref. B20285 ISIN Code. XS0222489873 TOTAL INTEREST AM... more »
-
LONDON--(BUSINESS WIRE)-- The Trafford Centre Finance Limited GBP 20,000,000 Class B2 Floating Rate Secured Notes Due 2038 ISSUE NAME. Our Ref. B20284 ISIN Code. XS0222489014 TOTAL INTEREST AMT. C... more »
-
LIMOGES, France--(BUSINESS WIRE)--Regulatory News: Legrand (Paris:LR) is actively implementing its development strategy with two acquisitions in the promising areas of assisted living, healthcare a... more »
-
Lanzamiento en Europa de la innovadora herramienta de cribado del cáncer de Antech, para la detección precoz del cáncer caninoViernheim, Alemania--(BUSINESS WIRE)--Antech, la empresa de diagnóstico veterinario que colabora con los profesionales veterinarios para la predicción, diagnóstico y control del bienestar y la enfe... more »
-
LONDON--(BUSINESS WIRE)-- 23 April 2024 Next 15 Group plc Transaction in own shares Next 15 Group plc (the “Company”) announces that, in accordance with the terms of its share buyback programme an... more »
-
TME Pharma Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two‑Year Survival in GLORIA Phase 1/2 Trial in Brain CancerBERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumo... more »
-
LONDON--(BUSINESS WIRE)-- The Trafford Centre Finance Limited GBP 188,500,000 Class A3 Floating Rate Secured Notes Due 2038 ISSUE NAME. Our Ref. B20276 ISIN Code. XS0222488396 TOTAL INTEREST AMT. ... more »